| 2-Piperazinone, 1-(tetrahydro-2H-pyran-4-yl)-, hydrochloride (1:1) |
1284244-13-8 |
C9H16N2O2.HCl |
| 9-Bromo-2-iodo-10-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine |
1403766-75-5 |
C12H10N2OBrI |
| Dimethyl 4-iodo-1H-pyrazole-3,5-dicarboxylate |
1027819-68-6 |
C7H7N2O4I |
| 2-Bromopyridine-3,4-diamine |
189230-41-9 |
C5H6N3Br |
| 2,6-Difluoro-3-(propylsulfonamido)benzoic acid |
1103234-56-5 |
C10H11NO4F2S |
| 2-Bromo-6-fluoro-3-nitrobenzoic acid |
1036388-81-4 |
C7H3NO4FBr |
| 9H-Purine, 2-chloro-9-methyl-6-(4-morpholinyl)- |
1148003-35-3 |
C10H12N5OCl |
| 2-(Methylsulfonyl)-2,5-Diazabicyclo[2.2.1]heptane |
944068-43-3 |
C6H12N2O2S |
| (4-Methylpiperidin-4-yl)pyrrolidin-1-ylmethanone |
885523-47-7 |
C11H20N2O |
| 1-(3-Azetidinyl)-3,3-difluoro-Pyrrolidine dihydrochloride |
1403766-97-1 |
C7H12N2F2.2[HCl] |
| 4-Piperidinamine, N-methyl-N-(tetrahydro-3-furanyl)- |
1257293-66-5 |
C10H20N2O |
| 1-(3-Azetidinyl)-4-piperidinol dihydrochloride |
810680-60-5 |
C8H16N2O.2[HCl] |
| 4-(Azetidin-3-yl)morpholine hydrochloride |
223381-71-3 |
C7H14N2O.HCl |
| N-methyl-N-(tetrahydrofuran-3-yl)azetidin-3-amine hydrochloride |
1403767-08-7 |
C8H16N2O.HCl |
| (3S)-1-(3-Azetidinyl)-3-fluoro-Pyrrolidine |
1403763-31-4 |
C7H13N2F |
| N-Ethyl-N-(tetrahydrofuran-3-yl)piperidin-4-amine dihydrochloride |
1439823-16-1 |
C11H22N2O.2[HCl] |
| Imidazo[1,2-d][1,4]benzoxazepine,9-bromo-5,6-dihydro-2-iodo- |
1282516-69-1 |
C11H8N2OBrI |
| 10-Bromo-2-iodo-9-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine |
1401305-33-6 |
C12H10N2OBrI |
| (R)-Hexahydro-oxazolo[3,4-a]pyrazin-3-one hydrochloride |
1212327-95-1 |
C6H10N2O2.HCl |
| 2-(2,2-Dimethylpiperazin-1-yl)acetamide hydrochloride |
1148003-49-9 |
C8H17N3O.2[HCl] |
